Literature DB >> 18175122

Planning transarterial radioembolization of colorectal liver metastases with Yttrium 90 microspheres: evaluation of a sequential diagnostic approach using radiologic and nuclear medicine imaging techniques.

Timm Denecke1, Ricarda Rühl, Bert Hildebrandt, Lars Stelter, Christian Grieser, Heiner Stiepani, Michael Werk, Pietr Podrabsky, Michail Plotkin, Holger Amthauer, Jens Ricke, Enrique Lopez Hänninen.   

Abstract

The purpose of the study was to establish a diagnostic approach to the preparation of patients with colorectal liver metastases considered for transarterial radioembolization (RE). Twenty-two patients sequentially underwent computed tomography (CT; thorax/abdomen), magnetic resonance imaging (MRI; liver; hepatocyte-specific contrast), positron emission tomography (PET/PET-CT; F18-fluoro-desoxy-glucose), and angiography with perfusion scintigraphy [planar imaging; tomography with integrated CT (SPECT-CT)]. The algorithm was continued when no contraindication or alternative treatment option was found. The impact of each test on the therapy decision and RE management was recorded. Patient evaluation using CT revealed contraindications for RE in 4/22 patients (18%). Of the remaining 18 patients, 2 were excluded and 3 were assigned to locally ablative treatment based on MRI and PET results (28%). The remaining 13 patients entered the planning algorithm: SPECT-CT revealed gastrointestinal tracer accumulations in 4 (31%) patients [SPECT, 2 (15%)], making a modified application necessary. In five patients (38%), planar scintigraphy revealed relevant hepatopulmonary shunting. Therapy was finally administered to all 13 patients without therapy-related pulmonary or gastrointestinal morbidity. Each part of the diagnostic algorithm showed a relevant impact on patient management. The sequential approach appears to be suitable and keeps the number of unnecessary treatments and therapy risks to a minimum.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18175122     DOI: 10.1007/s00330-007-0836-2

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  40 in total

1.  Right gastric artery embolization prior to treatment with yttrium-90 microspheres.

Authors:  Octavio Cosin; Jose Ignacio Bilbao; Sergio Alvarez; Esther de Luis; Alberto Alonso; Antonio Martinez-Cuesta
Journal:  Cardiovasc Intervent Radiol       Date:  2007 Jan-Feb       Impact factor: 2.740

2.  Multislice computed tomographic angiography for preinterventional planning of port placement for intra-arterial hepatic infusion chemotherapy.

Authors:  Lukas Lehmkuhl; Timm Denecke; Güsjal Warschewske; Bert Hildebrandt; Annett Nicolaou; Hanno Riess; Enrique Lopez Hänninen; Roland Felix; Jens Ricke
Journal:  J Comput Assist Tomogr       Date:  2007 Jan-Feb       Impact factor: 1.826

3.  Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: a risk-stratification analysis.

Authors:  James E Goin; Riad Salem; Brian I Carr; Janet E Dancey; Michael C Soulen; Jean-Francois H Geschwind; Kathleen Goin; Mark Van Buskirk; Kenneth Thurston
Journal:  J Vasc Interv Radiol       Date:  2005-02       Impact factor: 3.464

Review 4.  Cytotoxic chemotherapy for advanced colorectal cancer. Recent advances in management.

Authors:  Scott Kopetz; Paulo M Hoff
Journal:  Oncology (Williston Park)       Date:  2005-11       Impact factor: 2.990

5.  Liver malignancies: CT-guided interstitial brachytherapy in patients with unfavorable lesions for thermal ablation.

Authors:  Jens Ricke; Peter Wust; Gero Wieners; Alexander Beck; Chie Hee Cho; Max Seidensticker; Maciej Pech; Michael Werk; Christian Rosner; Enrique Lopez Hänninen; Torsten Freund; Roland Felix
Journal:  J Vasc Interv Radiol       Date:  2004-11       Impact factor: 3.464

6.  Randomised phase 2 trial of SIR-Spheres plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer.

Authors:  Guy Van Hazel; Anthony Blackwell; James Anderson; David Price; Paul Moroz; Geoff Bower; Giuseppe Cardaci; Bruce Gray
Journal:  J Surg Oncol       Date:  2004-11-01       Impact factor: 3.454

Review 7.  Yttrium-90 microsphere therapy for hepatic malignancy: devices, indications, technical considerations, and potential complications.

Authors:  Ravi Murthy; Rodolfo Nunez; Janio Szklaruk; William Erwin; David C Madoff; Sanjay Gupta; Kamran Ahrar; Michael J Wallace; Alan Cohen; Douglas M Coldwell; Andrew S Kennedy; Marshall E Hicks
Journal:  Radiographics       Date:  2005-10       Impact factor: 5.333

8.  Assessment of local control after laser-induced thermotherapy of liver metastases from colorectal cancer: contribution of FDG-PET in patients with clinical suspicion of progressive disease.

Authors:  T Denecke; I Steffen; B Hildebrandt; R Rühl; F Streitparth; L Lehmkuhl; J Langrehr; J Ricke; H Amthauer; E Lopez Hänninen
Journal:  Acta Radiol       Date:  2007-10       Impact factor: 1.990

9.  Interstitial hyperthermia of colorectal liver metastases with a US-guided Nd-YAG laser with a diffuser tip: a pilot clinical study.

Authors:  C P Nolsøe; S Torp-Pedersen; F Burcharth; T Horn; S Pedersen; N E Christensen; E S Olldag; P H Andersen; S Karstrup; T Lorentzen
Journal:  Radiology       Date:  1993-05       Impact factor: 11.105

10.  Gastrointestinal complications associated with hepatic arterial Yttrium-90 microsphere therapy.

Authors:  Ravi Murthy; Daniel B Brown; Riad Salem; Steven G Meranze; Douglas M Coldwell; Sunil Krishnan; Rodolfo Nunez; Amit Habbu; David Liu; William Ross; Alan M Cohen; Michael Censullo
Journal:  J Vasc Interv Radiol       Date:  2007-04       Impact factor: 3.464

View more
  12 in total

1.  Combining diffusion-weighted MRI with Gd-EOB-DTPA-enhanced MRI improves the detection of colorectal liver metastases.

Authors:  D-M Koh; D J Collins; T Wallace; I Chau; A M Riddell
Journal:  Br J Radiol       Date:  2011-12-13       Impact factor: 3.039

2.  (18)F-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography in the Management of Metastatic Colorectal Cancer: Are we there yet?

Authors:  Khalid Al-Naamani; Siham Al-Sinani
Journal:  Sultan Qaboos Univ Med J       Date:  2015-05-28

Review 3.  The role of (18)F-FDG positron emission tomography in the follow-up of liver tumors treated with (90)Yttrium radioembolization.

Authors:  Oreste Bagni; Luca Filippi; Orazio Schillaci
Journal:  Am J Nucl Med Mol Imaging       Date:  2015-02-15

Review 4.  The role of SPECT/CT in radioembolization of liver tumours.

Authors:  Hojjat Ahmadzadehfar; Heying Duan; Alexander R Haug; Stephan Walrand; Martha Hoffmann
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-01-18       Impact factor: 9.236

5.  Added value of FDG-PET imaging in the diagnostic workup for yttrium-90 radioembolisation in patients with colorectal cancer liver metastases.

Authors:  Charlotte E N M Rosenbaum; M A A J van den Bosch; W B Veldhuis; J E Huijbregts; M Koopman; M G E H Lam
Journal:  Eur Radiol       Date:  2012-10-31       Impact factor: 5.315

6.  The clinical value of MRI using single-shot echoplanar DWI to identify liver involvement in patients with advanced gastroenteropancreatic-neuroendocrine tumors (GEP-NETs), compared to FSE T2 and FFE T1 weighted image after i.v. Gd-EOB-DTPA contrast enhancement.

Authors:  Artur J Sankowski; Jarosław B Ćwikla; Mirosław L Nowicki; Sławomir Chaberek; Maciej Pech; Anna Lewczuk; Jerzy Walecki
Journal:  Med Sci Monit       Date:  2012-05

7.  Usefulness and pitfalls of MAA SPECT/CT in identifying digestive extrahepatic uptake when planning liver radioembolization.

Authors:  Laurence Lenoir; Julien Edeline; Yann Rolland; Marc Pracht; Jean-Luc Raoul; Valérie Ardisson; Patrick Bourguet; Bruno Clément; Eveline Boucher; Etienne Garin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-01-12       Impact factor: 9.236

Review 8.  Advances in SPECT for Optimizing the Liver Tumors Radioembolization Using Yttrium-90 Microspheres.

Authors:  Hoda Rezaei Roshan; Ahmadreza Azarm; Babak Mahmoudian; Jalil Pirayesh Islamian
Journal:  World J Nucl Med       Date:  2015 May-Aug

Review 9.  The role of 18F-FDG-PET and PET/CT in patients with colorectal liver metastases undergoing selective internal radiation therapy with yttrium-90: a first evidence-based review.

Authors:  Salvatore Annunziata; Giorgio Treglia; Carmelo Caldarella; Federica Galiandro
Journal:  ScientificWorldJournal       Date:  2014-02-02

Review 10.  Selective Interarterial Radiation Therapy (SIRT) in Colorectal Liver Metastases: How Do We Monitor Response?

Authors:  D Hipps; F Ausania; D M Manas; J D G Rose; J J French
Journal:  HPB Surg       Date:  2013-11-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.